← Back to Search

Peer Recovery Support for Substance Use Disorders (P2P Trial)

N/A

Waitlist Available

Led By Kristyn Zajac, PhD

Research Sponsored by UConn Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-25

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days from initiation of treatment

Awards & highlights

P2P Trial Summary

This trialwill study how to help 18-25 year olds stay in substance use treatment and reduce the risk of opiate addiction. It'll also look at risk factors & finances.

Who is the study for?

This trial is for young adults aged 18-25 who are starting outpatient treatment for substance use issues. It's designed to help them stick with their treatment program and not drop out early.Check my eligibility

What is being tested?

The study tests a new support service delivered by peers who have recovered from addiction themselves. This service aims to improve how well young adults follow through with their substance use disorder treatments.See study design

What are the potential side effects?

Since the intervention involves peer-delivered support rather than medication, there may be no direct medical side effects. However, participants might experience emotional or psychological impacts as they engage in the recovery process.

P2P Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 25 years old.

P2P Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days from initiation of treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days from initiation of treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days from initiation of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of missed sessions and no show sessions

Number of patients who dropout from substance use services

P2P Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peer Recovery Support - Delivered Dropout Prevention + Usual ServicesExperimental Treatment1 Intervention

clinics will continue to deliver their normal outpatient services plus the peer recovery support-delivered dropout prevention enhancement

Group II: Usual ServicesActive Control1 Intervention

clinics will continue to deliver their normal outpatient services

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor

211 Previous Clinical Trials

58,871 Total Patients Enrolled

University of Texas at AustinOTHER

353 Previous Clinical Trials

79,494 Total Patients Enrolled

Oregon Social Learning CenterOTHER

35 Previous Clinical Trials

9,025 Total Patients Enrolled

Media Library

Peer Recovery Support-Delivered Dropout Prevention enhancement Clinical Trial Eligibility Overview. Trial Name: NCT05374395 — N/A

Substance Use Disorder Research Study Groups: Usual Services, Peer Recovery Support - Delivered Dropout Prevention + Usual Services

Substance Use Disorder Clinical Trial 2023: Peer Recovery Support-Delivered Dropout Prevention enhancement Highlights & Side Effects. Trial Name: NCT05374395 — N/A

Peer Recovery Support-Delivered Dropout Prevention enhancement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05374395 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any enrollment opportunities currently available for this investigation?

"According to the clinicaltrials.gov website, this particular medical trial is not at present seeking out enrollees. Initially published on September 15th 2022 and lastly updated October 31st 2022, patients are unable to participate in this experiment currently; though there are other 359 studies that are actively looking for volunteers."

Answered by AI

Is geriatric participation permissible in this research endeavor?

"This particular medical experiment has strict age parameters, requiring participants to be between 18 and 25 years old. By contrast, there are significantly more studies available for those under 18 (75) and over 65 (253)."

Answered by AI

Is eligibility for this experiment open to me?

"This clinical trial is aiming to enroll 1750 individuals aged 18-25 who are suffering from Substance Use Disorder (SUD). Participants must additionally be commencing an outpatient treatment plan for their substance use problem."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults

Kristyn Zajac 2023. "Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05374395.